Posted from: Wednesday, February 01, 2017 - 05:55 PM - Present

Rhofade Approved to Treat Rosacea

January 18, 2017 – The U.S. FDA approved Rhofade™ (oxymetazoline) cream 1%, manufactured by Allergan.  Rhofade is indicated for treating adults who have rosacea. To alleviate the facial erythema (redness) often caused by rosacea, a common chronic skin condition that causes acne, dryness and redness, Rhofade is to be applied once a day. Allergan plans to launch Rhofade in May 2017.

Adverse reactions or quality problems experienced with the use of a recalled product may be reported to the FDA’s MedWatch Adverse Event Reporting Program either online, by U.S. mail or by fax.

Actual drug patent expiration dates and availability of new medications are subject to change due to patent litigation, settlement agreements, additional patents, exclusivities, and final FDA approval.  Distribution and availability of new medications at pharmacies may not occur immediately following FDA approval.  Patients are advised to speak with their healthcare professional or pharmacist regarding appropriateness as well as actual availability.

*This is provided for information only.  The reference to any medication above does not mean the medication is covered by your plan.

Last Updated Monday, May 29, 2017 - 11:02 AM.